1[1]Le Bars PL,Velasco FM,Ferguson JM,et al.Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.Neuropsychobiology,2002,45:19-26. 被引量：1
3[3]Poitrenaud J,Laurent B,Sebban C.Time course of age-associated memory impairment in 8 037 patients treated with Duxil for 6 months.Rev Geriatr,1994,19:531-538. 被引量：1
4[4]Flicker L,Grimley Evans G.Piracetam for dementia or cognitive impairment.Cochrane Database Syst Rev,2001,(2):CD001011. 被引量：1
5[5]Fioravanti M,Yanagi M.Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.Cochrane Database Syst Rev,2005,(2):CD000269. 被引量：1
6[6]Salloway S,Ferris S,Kluger A,et al.Efficacy of donepezil in mild cognitive impairment:a randomized placebo-controlled trial.Neurology,2004,63:651-657. 被引量：1
7[7]Sano M,Ernesto C,Thomas RG,et al.A controlled trial of selegiline,alpha-tocopherol,or both as treatment for Alzheimer's disease.The Alzheimer's Disease Cooperative Study.N Eng J Med,1997,336:1216-1222. 被引量：1
8[8]McGeer PL,Schulzer M,MeGeer EG.Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease:a review of 17 epidemiologic studies.Neurology,1996,47:425-432. 被引量：1
9[9]Aisen PS,Schafer KA,Grundman M,et al.Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression:a randomized controlled trial.JAMA,2003,289:2819-2826. 被引量：1
10[10]Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results From the Women's Health Initiative randomized controlled trial.JAMA,2002,288:321-333. 被引量：1
